nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A4—Temozolomide—malignant glioma	0.148	1	CbGbCtD
Lercanidipine—Lung infiltration—Carmustine—malignant glioma	0.0208	0.0358	CcSEcCtD
Lercanidipine—Necrosis—Carmustine—malignant glioma	0.0124	0.0214	CcSEcCtD
Lercanidipine—Cholestasis—Temozolomide—malignant glioma	0.0124	0.0214	CcSEcCtD
Lercanidipine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0115	0.0197	CcSEcCtD
Lercanidipine—Leukocytosis—Carmustine—malignant glioma	0.0104	0.0179	CcSEcCtD
Lercanidipine—Gynaecomastia—Carmustine—malignant glioma	0.00873	0.015	CcSEcCtD
Lercanidipine—Diabetes mellitus—Carmustine—malignant glioma	0.00814	0.014	CcSEcCtD
Lercanidipine—Hepatic failure—Temozolomide—malignant glioma	0.00762	0.0131	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00726	0.0125	CcSEcCtD
Lercanidipine—Hyponatraemia—Carmustine—malignant glioma	0.00711	0.0122	CcSEcCtD
Lercanidipine—Face oedema—Carmustine—malignant glioma	0.00684	0.0118	CcSEcCtD
Lercanidipine—Face oedema—Temozolomide—malignant glioma	0.00661	0.0114	CcSEcCtD
Lercanidipine—Muscular weakness—Carmustine—malignant glioma	0.00625	0.0108	CcSEcCtD
Lercanidipine—Breast disorder—Temozolomide—malignant glioma	0.00619	0.0106	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00616	0.0106	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00616	0.0106	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00604	0.0104	CcSEcCtD
Lercanidipine—Muscular weakness—Temozolomide—malignant glioma	0.00604	0.0104	CcSEcCtD
Lercanidipine—Pancytopenia—Carmustine—malignant glioma	0.00581	0.01	CcSEcCtD
Lercanidipine—Sweating increased—Temozolomide—malignant glioma	0.00576	0.00992	CcSEcCtD
Lercanidipine—Neutropenia—Carmustine—malignant glioma	0.00573	0.00985	CcSEcCtD
Lercanidipine—Pancytopenia—Temozolomide—malignant glioma	0.00562	0.00967	CcSEcCtD
Lercanidipine—Neutropenia—Temozolomide—malignant glioma	0.00553	0.00952	CcSEcCtD
Lercanidipine—Pollakiuria—Temozolomide—malignant glioma	0.00547	0.0094	CcSEcCtD
Lercanidipine—Erectile dysfunction—Temozolomide—malignant glioma	0.00545	0.00938	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Temozolomide—malignant glioma	0.0054	0.00929	CcSEcCtD
Lercanidipine—Renal failure—Carmustine—malignant glioma	0.00537	0.00923	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Carmustine—malignant glioma	0.00535	0.00921	CcSEcCtD
Lercanidipine—Stomatitis—Carmustine—malignant glioma	0.00532	0.00916	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00523	0.009	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00517	0.0089	CcSEcCtD
Lercanidipine—Stomatitis—Temozolomide—malignant glioma	0.00514	0.00885	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00499	0.00858	CcSEcCtD
Lercanidipine—Oedema peripheral—Carmustine—malignant glioma	0.00483	0.00831	CcSEcCtD
Lercanidipine—Connective tissue disorder—Carmustine—malignant glioma	0.00482	0.00829	CcSEcCtD
Lercanidipine—Hepatitis—Temozolomide—malignant glioma	0.00474	0.00815	CcSEcCtD
Lercanidipine—Urinary tract disorder—Temozolomide—malignant glioma	0.00468	0.00805	CcSEcCtD
Lercanidipine—Oedema peripheral—Temozolomide—malignant glioma	0.00467	0.00803	CcSEcCtD
Lercanidipine—Connective tissue disorder—Temozolomide—malignant glioma	0.00465	0.00801	CcSEcCtD
Lercanidipine—Urethral disorder—Temozolomide—malignant glioma	0.00464	0.00799	CcSEcCtD
Lercanidipine—Eye disorder—Carmustine—malignant glioma	0.00458	0.00788	CcSEcCtD
Lercanidipine—Flushing—Carmustine—malignant glioma	0.00455	0.00783	CcSEcCtD
Lercanidipine—Erythema multiforme—Temozolomide—malignant glioma	0.00448	0.0077	CcSEcCtD
Lercanidipine—Eye disorder—Temozolomide—malignant glioma	0.00443	0.00762	CcSEcCtD
Lercanidipine—Tinnitus—Temozolomide—malignant glioma	0.00442	0.0076	CcSEcCtD
Lercanidipine—Flushing—Temozolomide—malignant glioma	0.0044	0.00756	CcSEcCtD
Lercanidipine—Cardiac disorder—Temozolomide—malignant glioma	0.0044	0.00756	CcSEcCtD
Lercanidipine—Nifedipine—CYP2B6—malignant glioma	0.00438	0.504	CrCbGaD
Lercanidipine—Alopecia—Carmustine—malignant glioma	0.00433	0.00745	CcSEcCtD
Lercanidipine—Nicardipine—CYP2B6—malignant glioma	0.00431	0.496	CrCbGaD
Lercanidipine—Angiopathy—Temozolomide—malignant glioma	0.0043	0.00739	CcSEcCtD
Lercanidipine—Mental disorder—Carmustine—malignant glioma	0.00429	0.00739	CcSEcCtD
Lercanidipine—Immune system disorder—Temozolomide—malignant glioma	0.00428	0.00736	CcSEcCtD
Lercanidipine—Mediastinal disorder—Temozolomide—malignant glioma	0.00427	0.00734	CcSEcCtD
Lercanidipine—Erythema—Carmustine—malignant glioma	0.00427	0.00734	CcSEcCtD
Lercanidipine—Malnutrition—Carmustine—malignant glioma	0.00427	0.00734	CcSEcCtD
Lercanidipine—Alopecia—Temozolomide—malignant glioma	0.00419	0.0072	CcSEcCtD
Lercanidipine—Mental disorder—Temozolomide—malignant glioma	0.00415	0.00714	CcSEcCtD
Lercanidipine—Erythema—Temozolomide—malignant glioma	0.00412	0.00709	CcSEcCtD
Lercanidipine—Malnutrition—Temozolomide—malignant glioma	0.00412	0.00709	CcSEcCtD
Lercanidipine—Dysgeusia—Temozolomide—malignant glioma	0.00404	0.00695	CcSEcCtD
Lercanidipine—Vision blurred—Carmustine—malignant glioma	0.00402	0.00692	CcSEcCtD
Lercanidipine—Anaemia—Carmustine—malignant glioma	0.00394	0.00678	CcSEcCtD
Lercanidipine—Vision blurred—Temozolomide—malignant glioma	0.00389	0.00669	CcSEcCtD
Lercanidipine—Ill-defined disorder—Temozolomide—malignant glioma	0.00383	0.00658	CcSEcCtD
Lercanidipine—Anaemia—Temozolomide—malignant glioma	0.00381	0.00656	CcSEcCtD
Lercanidipine—Angioedema—Temozolomide—malignant glioma	0.00377	0.00648	CcSEcCtD
Lercanidipine—Malaise—Temozolomide—malignant glioma	0.00372	0.0064	CcSEcCtD
Lercanidipine—Vertigo—Temozolomide—malignant glioma	0.0037	0.00637	CcSEcCtD
Lercanidipine—Palpitations—Temozolomide—malignant glioma	0.00364	0.00627	CcSEcCtD
Lercanidipine—Chest pain—Carmustine—malignant glioma	0.00363	0.00625	CcSEcCtD
Lercanidipine—Myalgia—Carmustine—malignant glioma	0.00363	0.00625	CcSEcCtD
Lercanidipine—Anxiety—Carmustine—malignant glioma	0.00362	0.00623	CcSEcCtD
Lercanidipine—Cough—Temozolomide—malignant glioma	0.0036	0.00619	CcSEcCtD
Lercanidipine—Confusional state—Carmustine—malignant glioma	0.00351	0.00604	CcSEcCtD
Lercanidipine—Myalgia—Temozolomide—malignant glioma	0.00351	0.00604	CcSEcCtD
Lercanidipine—Arthralgia—Temozolomide—malignant glioma	0.00351	0.00604	CcSEcCtD
Lercanidipine—Anxiety—Temozolomide—malignant glioma	0.0035	0.00602	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00349	0.006	CcSEcCtD
Lercanidipine—Discomfort—Temozolomide—malignant glioma	0.00347	0.00597	CcSEcCtD
Lercanidipine—Dry mouth—Temozolomide—malignant glioma	0.00343	0.00591	CcSEcCtD
Lercanidipine—Thrombocytopenia—Carmustine—malignant glioma	0.00341	0.00587	CcSEcCtD
Lercanidipine—Tachycardia—Carmustine—malignant glioma	0.0034	0.00585	CcSEcCtD
Lercanidipine—Confusional state—Temozolomide—malignant glioma	0.00339	0.00584	CcSEcCtD
Lercanidipine—Anorexia—Carmustine—malignant glioma	0.00332	0.00571	CcSEcCtD
Lercanidipine—Nervous system disorder—Temozolomide—malignant glioma	0.0033	0.00568	CcSEcCtD
Lercanidipine—Thrombocytopenia—Temozolomide—malignant glioma	0.00329	0.00567	CcSEcCtD
Lercanidipine—Skin disorder—Temozolomide—malignant glioma	0.00327	0.00562	CcSEcCtD
Lercanidipine—Hypotension—Carmustine—malignant glioma	0.00325	0.0056	CcSEcCtD
Lercanidipine—Hyperhidrosis—Temozolomide—malignant glioma	0.00325	0.0056	CcSEcCtD
Lercanidipine—Anorexia—Temozolomide—malignant glioma	0.00321	0.00552	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00317	0.00546	CcSEcCtD
Lercanidipine—Insomnia—Carmustine—malignant glioma	0.00315	0.00542	CcSEcCtD
Lercanidipine—Paraesthesia—Carmustine—malignant glioma	0.00313	0.00538	CcSEcCtD
Lercanidipine—Dyspnoea—Carmustine—malignant glioma	0.0031	0.00534	CcSEcCtD
Lercanidipine—Somnolence—Carmustine—malignant glioma	0.0031	0.00533	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00307	0.00527	CcSEcCtD
Lercanidipine—Insomnia—Temozolomide—malignant glioma	0.00304	0.00524	CcSEcCtD
Lercanidipine—Decreased appetite—Carmustine—malignant glioma	0.00303	0.00521	CcSEcCtD
Lercanidipine—Paraesthesia—Temozolomide—malignant glioma	0.00302	0.0052	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00301	0.00517	CcSEcCtD
Lercanidipine—Dyspnoea—Temozolomide—malignant glioma	0.003	0.00516	CcSEcCtD
Lercanidipine—Somnolence—Temozolomide—malignant glioma	0.00299	0.00515	CcSEcCtD
Lercanidipine—Constipation—Carmustine—malignant glioma	0.00298	0.00512	CcSEcCtD
Lercanidipine—Dyspepsia—Temozolomide—malignant glioma	0.00296	0.0051	CcSEcCtD
Lercanidipine—Decreased appetite—Temozolomide—malignant glioma	0.00293	0.00503	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0029	0.005	CcSEcCtD
Lercanidipine—Fatigue—Temozolomide—malignant glioma	0.0029	0.00499	CcSEcCtD
Lercanidipine—Constipation—Temozolomide—malignant glioma	0.00288	0.00495	CcSEcCtD
Lercanidipine—Feeling abnormal—Carmustine—malignant glioma	0.00287	0.00494	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Carmustine—malignant glioma	0.00285	0.0049	CcSEcCtD
Lercanidipine—Feeling abnormal—Temozolomide—malignant glioma	0.00277	0.00477	CcSEcCtD
Lercanidipine—Abdominal pain—Carmustine—malignant glioma	0.00275	0.00474	CcSEcCtD
Lercanidipine—Body temperature increased—Carmustine—malignant glioma	0.00275	0.00474	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00275	0.00473	CcSEcCtD
Lercanidipine—Urticaria—Temozolomide—malignant glioma	0.00267	0.0046	CcSEcCtD
Lercanidipine—Abdominal pain—Temozolomide—malignant glioma	0.00266	0.00458	CcSEcCtD
Lercanidipine—Body temperature increased—Temozolomide—malignant glioma	0.00266	0.00458	CcSEcCtD
Lercanidipine—Hypersensitivity—Carmustine—malignant glioma	0.00257	0.00441	CcSEcCtD
Lercanidipine—Asthenia—Carmustine—malignant glioma	0.0025	0.0043	CcSEcCtD
Lercanidipine—Hypersensitivity—Temozolomide—malignant glioma	0.00248	0.00427	CcSEcCtD
Lercanidipine—Asthenia—Temozolomide—malignant glioma	0.00241	0.00415	CcSEcCtD
Lercanidipine—Diarrhoea—Carmustine—malignant glioma	0.00238	0.0041	CcSEcCtD
Lercanidipine—Pruritus—Temozolomide—malignant glioma	0.00238	0.0041	CcSEcCtD
Lercanidipine—Dizziness—Carmustine—malignant glioma	0.0023	0.00396	CcSEcCtD
Lercanidipine—Diarrhoea—Temozolomide—malignant glioma	0.0023	0.00396	CcSEcCtD
Lercanidipine—Dizziness—Temozolomide—malignant glioma	0.00223	0.00383	CcSEcCtD
Lercanidipine—Vomiting—Carmustine—malignant glioma	0.00221	0.00381	CcSEcCtD
Lercanidipine—Rash—Carmustine—malignant glioma	0.0022	0.00378	CcSEcCtD
Lercanidipine—Dermatitis—Carmustine—malignant glioma	0.00219	0.00377	CcSEcCtD
Lercanidipine—Headache—Carmustine—malignant glioma	0.00218	0.00375	CcSEcCtD
Lercanidipine—Vomiting—Temozolomide—malignant glioma	0.00214	0.00368	CcSEcCtD
Lercanidipine—Rash—Temozolomide—malignant glioma	0.00212	0.00365	CcSEcCtD
Lercanidipine—Dermatitis—Temozolomide—malignant glioma	0.00212	0.00365	CcSEcCtD
Lercanidipine—Headache—Temozolomide—malignant glioma	0.00211	0.00363	CcSEcCtD
Lercanidipine—Nausea—Carmustine—malignant glioma	0.00207	0.00356	CcSEcCtD
Lercanidipine—Nausea—Temozolomide—malignant glioma	0.002	0.00344	CcSEcCtD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000747	0.00285	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.00074	0.00282	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.00073	0.00278	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—malignant glioma	0.000695	0.00265	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—malignant glioma	0.000683	0.00261	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—SOX2—malignant glioma	0.000668	0.00255	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000648	0.00247	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—COX8A—malignant glioma	0.00062	0.00236	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TP53—malignant glioma	0.000613	0.00234	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—malignant glioma	0.000611	0.00233	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000607	0.00231	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—PTK2—malignant glioma	0.000605	0.00231	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000599	0.00228	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000599	0.00228	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RTEL1—malignant glioma	0.00058	0.00221	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.000574	0.00219	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.000566	0.00216	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000561	0.00214	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—COX8A—malignant glioma	0.000544	0.00208	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000539	0.00206	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TP53—malignant glioma	0.000539	0.00205	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—PTK2—malignant glioma	0.000531	0.00203	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ASMT—malignant glioma	0.000527	0.00201	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000526	0.00201	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000519	0.00198	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—FGFR1—malignant glioma	0.000506	0.00193	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—BCAN—malignant glioma	0.000495	0.00189	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000491	0.00187	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—KDR—malignant glioma	0.000476	0.00182	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MET—malignant glioma	0.000466	0.00178	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000465	0.00177	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ASMT—malignant glioma	0.000463	0.00177	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—FGFR1—malignant glioma	0.000444	0.00169	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—BCAN—malignant glioma	0.000435	0.00166	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PTK2—malignant glioma	0.000432	0.00165	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—PTPN11—malignant glioma	0.000431	0.00164	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000426	0.00162	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—HES1—malignant glioma	0.000424	0.00162	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—NCOR1—malignant glioma	0.000422	0.00161	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RTEL1—malignant glioma	0.00042	0.0016	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—KDR—malignant glioma	0.000418	0.0016	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000415	0.00158	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MET—malignant glioma	0.000409	0.00156	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000409	0.00156	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—IDH2—malignant glioma	0.000399	0.00152	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000399	0.00152	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000397	0.00151	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000391	0.00149	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MMP2—malignant glioma	0.000389	0.00148	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PTK2—malignant glioma	0.000379	0.00145	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—PTPN11—malignant glioma	0.000379	0.00144	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2B6—malignant glioma	0.000375	0.00143	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—HES1—malignant glioma	0.000373	0.00142	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—NCOR1—malignant glioma	0.00037	0.00141	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—FGFR1—malignant glioma	0.000361	0.00138	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—IDH2—malignant glioma	0.000351	0.00134	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—RAF1—malignant glioma	0.000344	0.00131	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000344	0.00131	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—IDH1—malignant glioma	0.000343	0.00131	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP2—malignant glioma	0.000342	0.0013	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—ERBB2—malignant glioma	0.000341	0.0013	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KDR—malignant glioma	0.00034	0.0013	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000339	0.00129	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—COX8A—malignant glioma	0.000333	0.00127	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MET—malignant glioma	0.000333	0.00127	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SPHK1—malignant glioma	0.000332	0.00127	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2B6—malignant glioma	0.00033	0.00126	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2C18—malignant glioma	0.000325	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—NOTCH1—malignant glioma	0.00032	0.00122	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—FGFR1—malignant glioma	0.000317	0.00121	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PTPN11—malignant glioma	0.000308	0.00117	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—RAF1—malignant glioma	0.000302	0.00115	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PPARG—malignant glioma	0.000302	0.00115	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—IDH1—malignant glioma	0.000302	0.00115	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—ERBB2—malignant glioma	0.000299	0.00114	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KDR—malignant glioma	0.000299	0.00114	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000298	0.00114	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000298	0.00114	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000295	0.00113	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MET—malignant glioma	0.000292	0.00111	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MMP9—malignant glioma	0.000292	0.00111	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SPHK1—malignant glioma	0.000292	0.00111	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000291	0.00111	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—AKT2—malignant glioma	0.000286	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2C18—malignant glioma	0.000286	0.00109	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ASMT—malignant glioma	0.000283	0.00108	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—NOTCH1—malignant glioma	0.000281	0.00107	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000278	0.00106	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP2—malignant glioma	0.000277	0.00106	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PTPN11—malignant glioma	0.00027	0.00103	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—BCAN—malignant glioma	0.000267	0.00102	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PPARG—malignant glioma	0.000265	0.00101	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—FGF2—malignant glioma	0.000263	0.001	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTT1—malignant glioma	0.000263	0.001	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—VEGFA—malignant glioma	0.000262	0.001	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000261	0.000994	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP9—malignant glioma	0.000257	0.000979	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT2—malignant glioma	0.000252	0.00096	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS1—malignant glioma	0.000247	0.000941	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RAF1—malignant glioma	0.000246	0.000937	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP2—malignant glioma	0.000244	0.000929	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—ERBB2—malignant glioma	0.000243	0.000927	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—COX8A—malignant glioma	0.000241	0.000919	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—EGFR—malignant glioma	0.000236	0.0009	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—FGF2—malignant glioma	0.000232	0.000883	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTT1—malignant glioma	0.000231	0.000882	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—VEGFA—malignant glioma	0.000231	0.000879	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—BCHE—malignant glioma	0.000229	0.000874	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SLC5A5—malignant glioma	0.000227	0.000864	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—KRAS—malignant glioma	0.000223	0.00085	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS1—malignant glioma	0.000217	0.000826	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RAF1—malignant glioma	0.000216	0.000823	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—IDH2—malignant glioma	0.000215	0.000819	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ERBB2—malignant glioma	0.000214	0.000814	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP9—malignant glioma	0.000208	0.000795	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—EGFR—malignant glioma	0.000207	0.000791	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ASMT—malignant glioma	0.000205	0.000781	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000202	0.00077	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—BCHE—malignant glioma	0.000201	0.000768	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SLC5A5—malignant glioma	0.000199	0.000759	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—KRAS—malignant glioma	0.000196	0.000747	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000195	0.000744	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000193	0.000736	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—BCAN—malignant glioma	0.000193	0.000735	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00019	0.000725	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—VEGFA—malignant glioma	0.000187	0.000714	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—STAT3—malignant glioma	0.000185	0.000707	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—IDH1—malignant glioma	0.000185	0.000704	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP9—malignant glioma	0.000183	0.000698	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTP1—malignant glioma	0.000182	0.000696	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000179	0.000682	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CAT—malignant glioma	0.000178	0.000677	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000175	0.000668	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—COX8A—malignant glioma	0.000171	0.000653	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EGFR—malignant glioma	0.000168	0.000642	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NCOR1—malignant glioma	0.000168	0.000639	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—VEGFA—malignant glioma	0.000164	0.000627	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—STAT3—malignant glioma	0.000163	0.000621	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—malignant glioma	0.00016	0.000612	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTP1—malignant glioma	0.00016	0.000611	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KRAS—malignant glioma	0.000159	0.000607	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CAT—malignant glioma	0.000156	0.000595	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—IDH2—malignant glioma	0.000155	0.000592	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EGFR—malignant glioma	0.000148	0.000564	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NCOR1—malignant glioma	0.000147	0.000562	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000146	0.000557	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ASMT—malignant glioma	0.000146	0.000556	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000142	0.00054	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—malignant glioma	0.000141	0.000538	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KRAS—malignant glioma	0.00014	0.000533	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000137	0.000522	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CAV1—malignant glioma	0.000137	0.000521	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—IDH1—malignant glioma	0.000134	0.000509	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000133	0.000506	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000129	0.000493	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000127	0.000483	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CG—malignant glioma	0.000125	0.000475	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—BCHE—malignant glioma	0.000123	0.00047	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000122	0.000465	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PPARG—malignant glioma	0.00012	0.000458	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CAV1—malignant glioma	0.00012	0.000458	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—AKT1—malignant glioma	0.000119	0.000455	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—COX8A—malignant glioma	0.000112	0.000427	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—IDH2—malignant glioma	0.00011	0.000421	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CD—malignant glioma	0.000109	0.000417	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CG—malignant glioma	0.000109	0.000417	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PPARG—malignant glioma	0.000106	0.000403	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT1—malignant glioma	0.000105	0.0004	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000104	0.000396	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000102	0.00039	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTP1—malignant glioma	9.82e-05	0.000374	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CD—malignant glioma	9.62e-05	0.000367	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS1—malignant glioma	9.59e-05	0.000366	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CAT—malignant glioma	9.55e-05	0.000364	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CB—malignant glioma	9.54e-05	0.000364	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ASMT—malignant glioma	9.53e-05	0.000363	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—IDH1—malignant glioma	9.5e-05	0.000362	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—malignant glioma	9.45e-05	0.00036	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SPHK1—malignant glioma	9.19e-05	0.00035	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NCOR1—malignant glioma	9.02e-05	0.000344	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2C18—malignant glioma	9e-05	0.000343	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—BCAN—malignant glioma	8.96e-05	0.000342	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—BCHE—malignant glioma	8.92e-05	0.00034	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC5A5—malignant glioma	8.81e-05	0.000336	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CB—malignant glioma	8.38e-05	0.00032	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—malignant glioma	8.31e-05	0.000317	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTEN—malignant glioma	8.24e-05	0.000314	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CAV1—malignant glioma	7.35e-05	0.00028	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—malignant glioma	7.28e-05	0.000278	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTEN—malignant glioma	7.24e-05	0.000276	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—IDH2—malignant glioma	7.22e-05	0.000275	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTP1—malignant glioma	7.1e-05	0.000271	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CAT—malignant glioma	6.91e-05	0.000263	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS1—malignant glioma	6.82e-05	0.00026	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.79e-05	0.000259	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CG—malignant glioma	6.7e-05	0.000255	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOR1—malignant glioma	6.52e-05	0.000249	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PPARG—malignant glioma	6.47e-05	0.000247	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—BCHE—malignant glioma	6.34e-05	0.000242	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.26e-05	0.000239	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—IDH1—malignant glioma	6.21e-05	0.000237	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SPHK1—malignant glioma	6.01e-05	0.000229	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CD—malignant glioma	5.89e-05	0.000225	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.89e-05	0.000224	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CA—malignant glioma	5.82e-05	0.000222	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CAV1—malignant glioma	5.32e-05	0.000203	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CB—malignant glioma	5.13e-05	0.000196	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CA—malignant glioma	5.11e-05	0.000195	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—malignant glioma	5.09e-05	0.000194	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTP1—malignant glioma	5.05e-05	0.000192	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CAT—malignant glioma	4.91e-05	0.000187	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.84e-05	0.000185	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—malignant glioma	4.76e-05	0.000181	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AKT1—malignant glioma	4.75e-05	0.000181	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PPARG—malignant glioma	4.67e-05	0.000178	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOR1—malignant glioma	4.64e-05	0.000177	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS1—malignant glioma	4.46e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTEN—malignant glioma	4.44e-05	0.000169	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.26e-05	0.000162	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AKT1—malignant glioma	4.17e-05	0.000159	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—BCHE—malignant glioma	4.15e-05	0.000158	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.1e-05	0.000156	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CAV1—malignant glioma	3.78e-05	0.000144	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.71e-05	0.000141	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—malignant glioma	3.68e-05	0.00014	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.44e-05	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PPARG—malignant glioma	3.32e-05	0.000127	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.3e-05	0.000126	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CAT—malignant glioma	3.21e-05	0.000122	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTEN—malignant glioma	3.21e-05	0.000122	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.13e-05	0.000119	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.03e-05	0.000116	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.03e-05	0.000115	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.64e-05	0.000101	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.61e-05	9.97e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AKT1—malignant glioma	2.56e-05	9.75e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CAV1—malignant glioma	2.47e-05	9.42e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTEN—malignant glioma	2.28e-05	8.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.26e-05	8.62e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.25e-05	8.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PPARG—malignant glioma	2.17e-05	8.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.98e-05	7.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKT1—malignant glioma	1.85e-05	7.05e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.72e-05	6.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.71e-05	6.52e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.61e-05	6.13e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTEN—malignant glioma	1.49e-05	5.68e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKT1—malignant glioma	1.31e-05	5.01e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.05e-05	4.01e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKT1—malignant glioma	8.59e-06	3.28e-05	CbGpPWpGaD
